Confibay
← All signals on August 27, 2026
Archive

ORCL

BUY
August 27, 2026Horizon stated in the case: 5 days to 90 days

Published once at least 12 trading days had closed after this run.

Summary

Overweight ORCL at 150.50 anchor into 90-day catalyst window (earnings + late-Oct Investor Day). Position sized below normal given ATR 6.59 (4.4% daily range) and leverage. Entry staged: scale on holds above 148.14 / 146.36, add on volume break of 153.83. Risk is a tight invalidation on sustained close below 145.86-146.36 cluster; survival stop 139.7-140 (1x ATR below 10EMA). Targets are 153.83 then 156.22-156.77 confluence; trail only on close above 156.77 toward 170.17. Use call spreads not naked calls (IV 78.2%). Time horizon 5 days to 90 days; cut if thesis breaks below support or dilution/litigation headline hits.

The case

Our analysis supports an Overweight with defined risk, not a core hold. 1) Technicals support tactical upside: +30.9% from 114.99 low, price +2.8% above 10EMA 146.36 and +6% above 50SMA 142.01, MACD bullish cross 1.59>0.92 histogram 0.67 expanding, RSI 56.15 neutral with room to 70, VWMA 148.14 confirms volume, Bollinger 42% not overbought. Higher low 142.07 on 8/20 held with RSI >48.87 and ATR compressing 8.12 to 6.59 signals coiling, not exhaustion. Bear-market structure remains: still 11.6% below declining 200SMA 170.17, 50SMA still falling, RSI failed vs 61.5 high, intraday volume 3.39M unsettled. Support cluster 145.86 Bollinger mid to 148.14 VWMA defines risk, waiting for 50SMA flatten misses catalyst. 2) Fundamentals are inflecting - revenue 19.18B +20.6% YoY, op income 6.95B best in 5Q, margin 36.2%, OCF 14.62B +137% YoY, FCF burn -11.48B to -1.87B in one quarter. Balance-sheet constraints argue for reduced sizing not short direction: debt 156.2B +50% YoY, D/E 388.87, tangible book -24.7B, TTM FCF -24.5B 5Q negative, capex 16.5B, net PPE +128.7% to 129.6B with 39.9B CIP, interest 1.44B +47%, working capital 14.1B to 4.8B, current ratio 1.115, one-time 2.46B gain inflated Nov net income to 6.13B vs normalized 4.16B, plus dilution (mandatory preferred + ATM hedging) and class action, and Nvidia +15% server hike pressuring OCI costs. RPO 638B is backlog not cash, subject to revenue recognition judgment. 3) Sentiment and catalyst tilt to Overweight: put/call OI 0.66, volume 0.73, confidence 68, social sentiment 2.8 (n=30), a market fear gauge at 58 rising, IV 78.2% high - bullish but not crowded, leaving squeeze potential vs short if RPO converts or AI deal announced. A 90-day catalyst watch with 330 target (+122%, Street 244 +62%) provides trading tailwind, not valuation floor. Beta 1.718 with Nasdaq/Nvidia tailwind helps 5-day alpha. 4) Risk-reward: Reward to 156.77 (4%) then gap to 170.17 (13%) outweighs downside to 145.86 (3%) if sized small and using spreads. Holding into earnings with cheap IV misses upside and selling into bounce without price confirmation fails - supports conditional Overweight vs outright Sell. Market analysis anchor 150.50 intraday vs news close 148.87 vs fundamentals 150.64. Difference 150.50 vs 148.87 = 1.09%, vs 150.64 = 0.09%, both <2% threshold - no material pipeline mismatch, just snapshot timing. Most recent is 150.50 intraday print; all entry/stops/targets based on 150.50.

What would weaken it

  • Leverage: debt 156.2B, D/E 388.87, tangible book -24.7B
  • Dilution/litigation overhang and Nvidia +15% cost pressure
  • Bear structure: 11.6% below 200SMA 170.17, 50SMA still falling

This case is at least 12 trading days old. The current day’s signals are for members.